Cargando…

Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents

BACKGROUND: Virotherapy represents a promising approach for ovarian cancer. In this regard, conditionally replicative adenovirus (CRAd) has been translated to the context of human clinical trials. Advanced design of CRAds has sought to exploit their capacity to induce anti-tumor immunization by conf...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Pastor, Rebeca, Ashshi, Ahmad Mohammad, El-Shemi, Adel Galal, Dmitriev, Igor P., Kashentseva, Elena A., Lu, Zhi Hong, Goedegebuure, S. Peter, Podhajcer, Osvaldo L., Curiel, David T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376676/ https://www.ncbi.nlm.nih.gov/pubmed/30767772 http://dx.doi.org/10.1186/s13048-019-0493-5

Ejemplares similares

Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer
por: Ashshi, Ahmad Mohammad, et al.
Publicado: (2016)

Personalized virotherapy in cancer
por: Cafferata, Eduardo G, et al.
Publicado: (2015)

Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma
por: Galal El-Shemi, A, et al.
Publicado: (2018)

The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary report
por: Refaat, Bassem, et al.
Publicado: (2015)

Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface
por: Lu, Zhi Hong, et al.
Publicado: (2022)

Development of an adenovirus vector vaccine platform for targeting dendritic cells
por: Sharma, Piyush K, et al.
Publicado: (2017)

Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
por: Sakhawat, Ali, et al.
Publicado: (2017)

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy
por: Refaat, Bassem, et al.
Publicado: (2015)

CryoEM Visualization of an Adenovirus Capsid-Incorporated HIV Antigen
por: Flatt, Justin W., et al.
Publicado: (2012)

Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters
por: Kim, Julius Woongki, et al.
Publicado: (2016)

Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report
por: Refaat, Bassem, et al.
Publicado: (2014)

Prolonged Prophylactic Protection from Botulism with a Single Adenovirus Treatment Promoting Serum Expression of a VHH-Based Antitoxin Protein
por: Mukherjee, Jean, et al.
Publicado: (2014)

Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
por: El-Shemi, Adel Galal, et al.
Publicado: (2016)

A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy
por: Hassan, Ahmed O., et al.
Publicado: (2019)

Erratum to: Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
por: El-Shemi, Adel Galal, et al.
Publicado: (2016)

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus
por: Kaliberov, Sergey A., et al.
Publicado: (2014)

Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation
por: Geng, Kexin, et al.
Publicado: (2023)

Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors
por: Xia, Xi, et al.
Publicado: (2011)

Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology
por: Tatzel, Katharina, et al.
Publicado: (2016)

Erratum: Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology
por: Tatzel, Katharina, et al.
Publicado: (2016)

Pegylated Interferon-α Modulates Liver Concentrations of Activin-A and Its Related Proteins in Normal Wistar Rat
por: Refaat, Bassem, et al.
Publicado: (2015)

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
por: Ylösmäki, Erkko, et al.
Publicado: (2021)

Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer
por: Kuroki, Lindsay M., et al.
Publicado: (2017)

Tumor Associated Stromal Cells Play a Critical Role on the Outcome of the Oncolytic Efficacy of Conditionally Replicative Adenoviruses
por: Lopez, M. Verónica, et al.
Publicado: (2009)

Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer
por: Cai, Zhonglin, et al.
Publicado: (2017)

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
por: Nguyen, Tien V, et al.
Publicado: (2018)

The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
por: Tate, Sophia J., et al.
Publicado: (2021)

Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients
por: Agarwal, Payal, et al.
Publicado: (2021)

A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting
por: Lu, Zhi Hong, et al.
Publicado: (2020)

Curative one-shot systemic virotherapy in murine myeloma
por: Naik, Shruthi, et al.
Publicado: (2012)

LOCL-03 INTRATUMORAL DELIVERY OF CONDITIONALLY REPLICATIVE HUMAN ADENOVIRUS 657 EXPRESSING THE IMMUNE CO-STIMULATOR CD40L (CRAD657-CD40L) AS A POTENTIALLY PROMISING TREATMENT FOR RECURRENT PEDIATRIC HIGH GRADE GLIOMA
por: Webb, Mason, et al.
Publicado: (2022)

Knockdown of CRAD suppresses the growth and promotes the apoptosis of human lung cancer cells via Claudin 4
por: Cui, Anfang, et al.
Publicado: (2020)

COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
por: Panek, Wojciech K., et al.
Publicado: (2017)

Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy
por: Gómez, Ana, et al.
Publicado: (2020)

Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies
por: Cunliffe, Tabitha G., et al.
Publicado: (2020)

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2020)

Home-based intensive treatment of chronic radiation-associated dysphagia in head and neck cancer survivors (HIT-CRAD trial)
por: Massonet, Hanne, et al.
Publicado: (2022)

Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
por: Wilkinson-Ryan, Ivy, et al.
Publicado: (2015)

In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer
por: Alfano, Ana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s93htm9p9v467n4m5fklh8gn8p